Spots Global Cancer Trial Database for radiation therapy
Every month we try and update this database with for radiation therapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma | NCT02567435 | Alveolar Rhabdo... Botryoid-Type E... Embryonal Rhabd... Rhabdomyosarcom... Sclerosing Rhab... Spindle Cell Rh... | Cyclophosphamid... Dactinomycin Irinotecan Hydr... Laboratory Biom... Questionnaire A... Radiation Thera... Temsirolimus Vincristine Sul... Vinorelbine | - 40 Years | National Cancer Institute (NCI) | |
Reducing Acute Upper Gastrointestinal Side-Effects of Thoracic Irradiation | NCT05659576 | Radiation Esoph... | Sucralfate Usual Care One consent Two consent | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases | NCT00238251 | Lung Cancer Metastatic Canc... | gefitinib temozolomide radiation thera... | 18 Years - | Swiss Group for Clinical Cancer Research | |
Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal Cancer | NCT02389751 | Gastroesophagea... Malignant Neopl... Malignant Neopl... Stage IIA Esoph... Stage IIB Esoph... Stage IIIA Esop... Stage IIIB Esop... Stage IIIC Esop... | Carboplatin Ganetespib Paclitaxel Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | NCT00002623 | Lung Cancer | carboplatin cisplatin conventional su... radiation thera... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
A Study of SBRT for Squamous Cell Carcinoma of the Head and Neck | NCT04435938 | Head and Neck N... Squamous Cell C... Squamous Skin C... | Stereotactic Bo... | 60 Years - | McMaster University | |
Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT02337426 | Adult Brain Gli... Adult Giant Cel... Adult Gliosarco... | Dimethyl Fumara... Temozolomide Radiation Thera... | 18 Years - | Virginia Commonwealth University | |
Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole | NCT00077168 | Breast Cancer | anastrozole tamoxifen citra... adjuvant therap... radiation thera... | 40 Years - 70 Years | National Cancer Institute (NCI) | |
Phase II Trial for Large ER-Negative Breast Cancers | NCT01869192 | Malignant Neopl... | Epirubicin Cyclophosphamid... Docetaxel Capecitabine Radiation Thera... | 18 Years - | University of Colorado, Denver | |
Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer | NCT00033449 | Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... | gefitinib radiation thera... cisplatin laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790M | NCT02972333 | EGFR-TKI Resist... Nonsmall Cell L... AZD9291 Brain Metastase... | AZD9291 80mg or... Radiation thera... | 18 Years - | Shandong Cancer Hospital and Institute | |
Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer | NCT03104439 | Microsatellite ... Pancreatic Canc... MSI High Colore... | Nivolumab Ipilimumab Radiation Thera... | 18 Years - | Massachusetts General Hospital | |
Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer | NCT00002689 | Pancreatic Canc... | dexamethasone fluorouracil brachytherapy phosphorus P32 radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes | NCT04183218 | Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Localized Esoph... Localized Lung ... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Stage 0 Lung Ca... Stage I Lung Ca... Stage IA1 Lung ... Stage IA2 Lung ... Stage IA3 Lung ... Stage IB Lung C... Stage II Lung C... Stage IIA Lung ... Stage IIB Lung ... Stage III Lung ... Stage IIIA Lung... Stage IIIB Lung... Stage IIIC Lung... | Biospecimen Col... Cardiac Event M... Chemoradiothera... Radiation Thera... | 18 Years - | Mayo Clinic | |
Reduced Radiation in Patients With Diffuse Large B-cell Lymphoma | NCT01186978 | Diffuse Large B... | Radiation Thera... | 18 Years - 80 Years | Duke University | |
Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide | NCT00250211 | Glioblastoma Glioma | Functional MRI ... | 18 Years - 65 Years | AHS Cancer Control Alberta | |
Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer | NCT00032006 | Prostate Cancer | brachytherapy radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer | NCT00005587 | Breast Cancer | radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia | NCT00003868 | Leukemia | cyclophosphamid... methotrexate allogeneic bone... peripheral bloo... iodine I 131 mo... radiation thera... | 2 Years - 55 Years | Fred Hutchinson Cancer Center | |
A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection | NCT02792582 | Craniopharyngio... | Proton Therapy Surgery | - 21 Years | St. Jude Children's Research Hospital | |
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia | NCT00002549 | Leukemia | filgrastim busulfan cyclophosphamid... cytarabine daunorubicin hy... etoposide idarubicin mesna mitoxantrone hy... allogeneic bone... autologous bone... peripheral bloo... radiation thera... | 15 Years - 60 Years | National Cancer Institute (NCI) | |
Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients. | NCT04229459 | Esophageal Squa... | Cisplatin 5-FU Radiation thera... Cetuximab Nivolumab | 18 Years - | Rabin Medical Center | |
Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas | NCT02037230 | Adenocarcinoma ... | MK-1775 Gemcitabine Radiation Thera... | 18 Years - | University of Michigan Rogel Cancer Center | |
Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer | NCT00003364 | Lung Cancer | cisplatin cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... radiation thera... | - 74 Years | National Cancer Institute (NCI) | |
S9709, Laser Surgery Plus Radiation Therapy in Treating Patients With Early Stage Cancer of the Larynx | NCT00003040 | Head and Neck C... | laser surgery radiation thera... | 18 Years - | SWOG Cancer Research Network | |
Neutron Radiation Therapy and Pembrolizumab in Treating Participants With Advanced Urothelial Carcinoma | NCT03486197 | Urothelial Carc... | Laboratory Biom... Pembrolizumab Radiation Thera... | 18 Years - | University of Washington | |
3D Specimen Maps for RT Planning | NCT05743569 | Head and Neck C... Head and Neck S... Radiation Thera... | 28 Years - | Vanderbilt University Medical Center | ||
Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas | NCT00003216 | Pancreatic Canc... | fluorouracil gemcitabine hyd... radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas | NCT00042991 | Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... | gefitinib radiation thera... pharmacological... laboratory biom... | 3 Years - 21 Years | National Cancer Institute (NCI) | |
Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia | NCT00040690 | Leukemia Lymphoma | filgrastim cyclophosphamid... cytarabine doxorubicin hyd... etoposide ifosfamide leucovorin calc... methotrexate vincristine sul... radiation thera... | 16 Years - | National Cancer Institute (NCI) | |
Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer | NCT00613080 | Colorectal Canc... | capecitabine oxaliplatin resection radiation thera... FOLFOX | 18 Years - | Radiation Therapy Oncology Group | |
Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site | NCT05110781 | Locally Advance... Resectable Cuta... Stage III Cutan... | Atezolizumab Radiation Thera... Therapeutic Con... | 18 Years - | University of California, Davis | |
Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease | NCT00004010 | Lymphoma | bleomycin sulfa... filgrastim ABVD regimen cyclophosphamid... dacarbazine doxorubicin hyd... etoposide prednisone procarbazine hy... vinblastine sul... vincristine sul... radiation thera... | - 21 Years | Children's Oncology Group | |
Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes | NCT00007904 | Breast Cancer | filgrastim cyclophosphamid... doxorubicin hyd... paclitaxel tamoxifen citra... adjuvant therap... radiation thera... | 18 Years - | Case Comprehensive Cancer Center | |
High-Dose 3-Dimensional Conformal Radiation Therapy in Treating Patients With Inoperable Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer | NCT00062335 | Lung Cancer | radiation thera... | - | European Organisation for Research and Treatment of Cancer - EORTC | |
A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed Glioblastoma | NCT04324840 | Glioblastoma | CC-90010 Temozolomide Radiotherapy | 18 Years - | Celgene | |
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT00553462 | Lung Cancer | carboplatin erlotinib hydro... paclitaxel albu... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
Dose-finding Study of Metformin With Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma | NCT02325401 | Head and Neck C... | Metformin Cisplatin Radiation Thera... | 18 Years - | University of Cincinnati | |
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer | NCT00601406 | Breast Cancer Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton... Prostate Cancer Sarcoma Vaginal Cancer Vulvar Cancer | gene expression... gene rearrangem... polymorphism an... laboratory biom... radiation thera... | - | National Cancer Institute (NCI) | |
Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC) | NCT02934503 | Small Cell Lung... | Pembrolizumab Cisplatin Carboplatin Etoposide Radiation thera... | 19 Years - | NYU Langone Health | |
Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors | NCT00302159 | High Grade Glio... Brain Tumors | adjuvant therap... Temozolomide Valproic Acid Radiation thera... | 18 Years - 90 Years | National Institutes of Health Clinical Center (CC) | |
ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT00770471 | Brain and Centr... | temozolomide veliparib DNA methylation... gene expression... mutation analys... proteomic profi... high performanc... immunoenzyme te... laboratory biom... mass spectromet... pharmacogenomic... pharmacological... adjuvant therap... radiation thera... | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT00099125 | Brain and Centr... | irinotecan hydr... temozolomide adjuvant therap... radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
Amifostine With IMRT for Submandibular and Sublingual Salivary Sparing During Head and Neck Cancer Treatment | NCT00409331 | Head and Neck C... | Amifostine Intensity- Modu... | 18 Years - | M.D. Anderson Cancer Center | |
Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate Cancer | NCT03159676 | Prostate Cancer | Proton beam | 18 Years - | Mayo Clinic | |
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery | NCT03180268 | Grade II Mening... Intracranial Me... | Clinical Observ... Radiation Thera... | 18 Years - | NRG Oncology | |
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer | NCT00109850 | Esophageal Canc... | cetuximab cisplatin irinotecan hydr... radiation thera... | 18 Years - | SWOG Cancer Research Network | |
Stereotactic Ablative Radiotherapy for Early-stage Glottic Larynx Cancer | NCT03548285 | Glottic Carcino... | Radiation thera... | 18 Years - 120 Years | University of Texas Southwestern Medical Center | |
SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed | NCT00002551 | Colorectal Canc... | fluorouracil leucovorin calc... levamisole hydr... radiation thera... | 18 Years - | SWOG Cancer Research Network | |
FACBC Outcomes for Post Prostatectomy | NCT01666808 | Prostate Cancer | FACBC Radiation thera... | 18 Years - 95 Years | Emory University | |
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia | NCT00004905 | Leukemia | filgrastim recombinant int... cyclophosphamid... cytarabine etoposide idarubicin peripheral bloo... radiation thera... | 18 Years - 60 Years | National Cancer Institute (NCI) | |
Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma | NCT01400672 | Diffuse Intrins... | Tumor Lysate Va... Imiquimod Radiation thera... | 3 Years - | Masonic Cancer Center, University of Minnesota | |
Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors | NCT03194906 | Glioma of Brain Craniopharyngio... Ependymoma Germ Cell Tumor | Memantine Placebo Cognitive Asses... | 6 Years - 21 Years | St. Jude Children's Research Hospital | |
Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma | NCT00002840 | Brain and Centr... | lomustine procarbazine hy... vincristine sul... radiation thera... | 16 Years - 69 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
Bone Marrow Transplantation in Treating Patients With Lymphoma | NCT00002829 | Lymphoma | Recombinant Int... Cyclophosphamid... Etoposide Mesna Bone Marrow Tra... Radiation Thera... | 15 Years - 60 Years | M.D. Anderson Cancer Center | |
Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma | NCT05336383 | Multiple Myelom... Plasma Cell Neo... Malignant Plasm... | Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT) | NCT00311857 | Glioblastoma Mu... | Cetuximab Temozolomide Radiation thera... | 18 Years - 70 Years | Heidelberg University | |
Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT00589056 | Lung Cancer | cisplatin etoposide nelfinavir mesy... protein express... immunohistochem... laboratory biom... biopsy radiation thera... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
Checkpoint Inhibitor and Radiation Therapy in Bulky, Node-Positive Bladder Cancer | NCT04779489 | Bladder Cancer | personalized ul... | 18 Years - | University of Texas Southwestern Medical Center | |
Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer | NCT00423475 | Prostate Cancer | goserelin aceta... adjuvant therap... radiation thera... | 18 Years - 120 Years | UNICANCER | |
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer | NCT00005638 | Esophageal Canc... Gastric Cancer | cisplatin irinotecan hydr... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
De-escalation of Radiation Dose in HPV-associated OPC Utilising FMISO PET (DE-RADIATE) | NCT06307015 | HPV Positive Or... | De-escalation Standard of car... | 18 Years - | Royal North Shore Hospital | |
An Exploratory Trial to Evaluate Efficacy and Safety for Combination Treatment of Adenovirus Double Suicide Gene Therapy | NCT04739046 | Pancreas Cancer | Theragene arm | 19 Years - 75 Years | Seoul National University Bundang Hospital | |
MPDL3280A With Chemoradiation for Lung Cancer | NCT02525757 | Lung Cancer Non-Small Cell ... | MPDL3280A Carboplatin Paclitaxel Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
UNC Metastatic Cancer Radiation Therapy Registry | NCT06306924 | Cancer Metastatic Canc... | Radiation thera... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia | NCT00004128 | Leukemia | aldesleukin filgrastim busulfan cyclophosphamid... cytarabine daunorubicin hy... etoposide autologous bone... peripheral bloo... radiation thera... | 15 Years - 60 Years | National Cancer Institute (NCI) | |
Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer | NCT01540994 | Prostatic Neopl... | radiation thera... | 50 Years - 90 Years | Sharp HealthCare | |
Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients | NCT03921684 | Rectal Cancer | Capecitabine Radiation thera... mFOLFOX6 Nivolumab | 18 Years - | Rabin Medical Center | |
Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM) | NCT02057939 | Prostate Cancer | enzalutamide Androgen Depriv... Radiation Thera... | 18 Years - | Duke University | |
Radiation Therapy and Cardiac Enzymes | NCT00777751 | Tumor | 18 Years - | M.D. Anderson Cancer Center | ||
Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases | NCT00002708 | Metastatic Canc... | surgical proced... radiation thera... stereotactic ra... | 18 Years - | Radiation Therapy Oncology Group | |
Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic Cancer | NCT02184533 | Adenocarcinoma ... Hormone-resista... Recurrent Prost... Stage IV Prosta... Multiple Myelom... Plasmacytoma | sodium selenite radiation thera... laboratory biom... pharmacological... questionnaire a... | 18 Years - | Stanford University | |
A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer | NCT01291407 | Gastrointestina... Gastric Cancer | S-1 S-1 S-1 S-1 S-1 S-1 | 18 Years - 75 Years | ChineseAMS | |
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the Vulva | NCT00006096 | Vulvar Cancer | cisplatin radiation thera... | - | GOG Foundation | |
Outcomes and Cosmesis With Whole Breast Irradiation and Boost | NCT06295744 | Early-stage Bre... | Radiation Thera... | 18 Years - | University of Wisconsin, Madison | |
Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer | NCT00004917 | Anemia Head and Neck C... | epoetin alfa cisplatin radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma | NCT00408005 | T Acute Lymphob... T Lymphoblastic... | Asparaginase Cyclophosphamid... Cytarabine Daunorubicin Hy... Dexamethasone Doxorubicin Hyd... Laboratory Biom... Leucovorin Calc... Mercaptopurine Methotrexate Nelarabine Pegaspargase Prednisone Radiation Thera... Thioguanine Vincristine Sul... | 1 Year - 30 Years | National Cancer Institute (NCI) | |
De-escalation of Radiation Dose in HPV-associated OPC Utilising FMISO PET (DE-RADIATE) | NCT06307015 | HPV Positive Or... | De-escalation Standard of car... | 18 Years - | Royal North Shore Hospital | |
Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal Cancer | NCT00084591 | Colorectal Canc... | capecitabine conventional su... neoadjuvant the... radiation thera... | 18 Years - | Fox Chase Cancer Center | |
Artificial Intelligence for Prostate Cancer Treatment Planning | NCT04441775 | Prostate Cancer Artificial Inte... Radiotherapy | AI-assisted RT ... | 21 Years - 90 Years | Dartmouth-Hitchcock Medical Center |